256 related articles for article (PubMed ID: 19144302)
1. Safety of intranasal corticosteroids in acute rhinosinusitis.
Demoly P
Am J Otolaryngol; 2008; 29(6):403-13. PubMed ID: 19144302
[TBL] [Abstract][Full Text] [Related]
2. Safety update regarding intranasal corticosteroids for the treatment of allergic rhinitis.
Blaiss MS
Allergy Asthma Proc; 2011; 32(6):413-8. PubMed ID: 22221434
[TBL] [Abstract][Full Text] [Related]
3. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis.
Chong LY; Head K; Hopkins C; Philpott C; Schilder AG; Burton MJ
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011996. PubMed ID: 27115217
[TBL] [Abstract][Full Text] [Related]
4. Different types of intranasal steroids for chronic rhinosinusitis.
Chong LY; Head K; Hopkins C; Philpott C; Burton MJ; Schilder AG
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011993. PubMed ID: 27115215
[TBL] [Abstract][Full Text] [Related]
5. Systemic effects of intranasal steroids: an endocrinologist's perspective.
Allen DB
J Allergy Clin Immunol; 2000 Oct; 106(4 Suppl):S179-90. PubMed ID: 11032642
[TBL] [Abstract][Full Text] [Related]
6. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications.
Derendorf H; Meltzer EO
Allergy; 2008 Oct; 63(10):1292-300. PubMed ID: 18782107
[TBL] [Abstract][Full Text] [Related]
7. A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis.
Lumry WR
J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 1):S150-8. PubMed ID: 10518812
[TBL] [Abstract][Full Text] [Related]
8. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. 194-079 Study Group.
Mandl M; Nolop K; Lutsky BN
Ann Allergy Asthma Immunol; 1997 Oct; 79(4):370-8. PubMed ID: 9357385
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Index (TIX) for intranasal corticosteroids in the treatment of allergic rhinitis.
Schafer T; Schnoor M; Wagenmann M; Klimek L; Bachert C
Rhinology; 2011 Aug; 49(3):272-280. PubMed ID: 21858255
[TBL] [Abstract][Full Text] [Related]
10. A review of the pharmacology and pharmacokinetics of inhaled fluticasone propionate and mometasone furoate.
Crim C; Pierre LN; Daley-Yates PT
Clin Ther; 2001 Sep; 23(9):1339-54. PubMed ID: 11589253
[TBL] [Abstract][Full Text] [Related]
11. Mometasone furoate. A review of its intranasal use in allergic rhinitis.
Onrust SV; Lamb HM
Drugs; 1998 Oct; 56(4):725-45. PubMed ID: 9806113
[TBL] [Abstract][Full Text] [Related]
12. Inhaled corticosteroids in children with persistent asthma: dose-response effects on growth.
Pruteanu AI; Chauhan BF; Zhang L; Prietsch SO; Ducharme FM
Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD009878. PubMed ID: 25030199
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of intranasal corticosteroids.
Szefler SJ
J Allergy Clin Immunol; 2001 Jul; 108(1 Suppl):S26-31. PubMed ID: 11449203
[TBL] [Abstract][Full Text] [Related]
14. New patents of fixed combinations of nasal antihistamines and corticosteroids in allergic rhinitis.
Wolthers OD
Recent Pat Inflamm Allergy Drug Discov; 2013 Sep; 7(3):223-8. PubMed ID: 23862774
[TBL] [Abstract][Full Text] [Related]
15. Local and systemic safety of intranasal corticosteroids.
Sastre J; Mosges R
J Investig Allergol Clin Immunol; 2012; 22(1):1-12. PubMed ID: 22448448
[TBL] [Abstract][Full Text] [Related]
16. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. The 194-079 Study Group.
Mandl M; Nolop K; Lutsky BN
Ann Allergy Asthma Immunol; 1997 Sep; 79(3):237-45. PubMed ID: 9305231
[TBL] [Abstract][Full Text] [Related]
17. Safety of intranasal corticosteroid sprays during pregnancy: an updated review.
Alhussien AH; Alhedaithy RA; Alsaleh SA
Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):325-333. PubMed ID: 29164323
[TBL] [Abstract][Full Text] [Related]
18. Safety and tolerability of fluticasone furoate nasal spray once daily in paediatric patients aged 6-11 years with allergic rhinitis: subanalysis of three randomized, double-blind, placebo-controlled, multicentre studies.
Meltzer EO; Tripathy I; Máspero JF; Wu W; Philpot E
Clin Drug Investig; 2009; 29(2):79-86. PubMed ID: 19133703
[TBL] [Abstract][Full Text] [Related]
19. Relationship between systemic corticosteroid exposure and growth velocity: development and validation of a pharmacokinetic/pharmacodynamic model.
Daley-Yates PT; Richards DH
Clin Ther; 2004 Nov; 26(11):1905-19. PubMed ID: 15639702
[TBL] [Abstract][Full Text] [Related]
20. Intranasal corticosteroids for allergic rhinitis.
Trangsrud AJ; Whitaker AL; Small RE
Pharmacotherapy; 2002 Nov; 22(11):1458-67. PubMed ID: 12432972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
